Reduced Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Therapy in People With Type 1 Diabetes and Genetic Forms of Obesity

J Diabetes Sci Technol. 2024 Apr 17:19322968241245680. doi: 10.1177/19322968241245680. Online ahead of print.

Authors

Matthew P Klein¹, Halis Kaan Akturk¹, Janet K Snell-Bergeon¹, Viral N Shah²

Affiliations

¹ Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
² Indiana University School of Medicine, Indianapolis, IN, USA.

PMID: 38629877
DOI: 10.1177/19322968241245680

Abstract

This article has been temporarily removed for correction.

Keywords: genetic mutations; genetics; glucagon-like peptide-1 receptor agonist (GLP-1 RA); obesity; type 1 diabetes mellitus.